Further studies integrated with genetic polymorphisms of OCT3, MATE1, MATE 2, and PMAT should investigate their potential as predictors of the effectiveness of metformin treatment in PCOS patients. The gene discussed is SLC47A1; the disease is polycystic ovary syndrome.